Featured Solution: “Clinical Data Sharing: A Proposed Methodology to Enable Data Privacy While Improving Secondary Use” (Privacy Methodology) Secondary use of clinical trial data honors a patient’s contribution to clinical development by using data to the fullest extent possible while respecting the wishes of the individual patient, enhancing innovative quality advancements across drug development and…
Explore
Overview TransCelerate held its most widely attended Realization Summit to date! The event welcomed more than 500 attendees representing more than 25 countries and 19 Member Companies. The two-day event offered all attendees, virtual and in-person, the opportunity to directly connect with initiative experts, senior industry representatives and colleagues across all levels of the research…
Explore
TransCelerate remains convinced that the only way these challenging problems can be addressed is through collaboration. Since launching in 2012, TransCelerate has invested in simplifying and accelerating the research and development of innovative new therapies. Through tackling initiatives such as Risk Based Monitoring, Site Qualification & Training, and the Comparator Network, we are building the bridge to…
Explore
Overview TransCelerate held its first annual Realization Summit which provided attendees with an opportunity to learn about initiative solutions and delivery, engage in one-on-one conversations with initiative experts, as well as discussions with industry representatives from the entire clinical trial ecosystem. Three Tracks The two-day event featured dedicated time to visit interactive learning tables hosted…
Explore
Blog October 20, 2022
2022 marks the Tenth Anniversary of TransCelerate. 150 current and past members, contributors, and other industry stakeholders from around the world convened at the Franklin Institute in Philadelphia on October 6, 2022, to celebrate. At its founding, TransCelerate’s goal was to tackle five persistent issues in clinical trials: development of a shared user interface for…
Explore
The Latest The eLabels Initiative and the Art of the Possible Industry Lens Five Opportunities to Improve Communication & Information Exchange with Clinical Research Participants By Roslyn F. Schneider MD, MSc, Global Patient Affairs Lead, Pfizer Spotlight Erica Drew at AstraZeneca and Nish Chudasama at Bristol-Myers Squibb discuss the Value that the Comparator Network Initiative…
Explore
News & Media
Explore
News & Media
Explore
Blog December 5, 2023
For the second installment of our Interpretation of Pharmacovigilance Guidances & Regulations (IGR PV) Initiative blog series, we will take a deep dive into the initiative and its goals. Established in 2018, this initiative germinated when it became apparent that some of the regulations issued by global Health Authorities can be unclear and/or challenging for…
Explore
News & Media
Explore
